跳至主要内容
临床试验/CTRI/2016/05/006970
CTRI/2016/05/006970已完成3 期

Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) - ASPIRI

Eunice Kennedy Shriver National Institute of Child Health and Human Development0 个研究点目标入组 4,829 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
4,829

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Nulliparous women between 18 â?? 40 years of age.
  • -No more than two previous first trimester pregnancy losses
  • -No medical contraindications to aspirin;
  • -Single live intrauterine pregnancy (IUP) between 6 0/7 and 13 6/7 weeks GA corroborated by an early dating ultrasound and with heart rate greater than 110 bpm

排除标准

  • -Women prescribed daily aspirin for more than 7 days
  • -Multiple gestations;
  • -Fetal anomaly by ultrasound (Note most fetal anomalies are not detectable by ultrasounds done at this early gestation. Subsequent discovery of a fetal anomaly is not viewed as an exclusion
  • -Hemoglobin < 7.0 gm/dl at screening
  • -Any other medical conditions that may be considered a contraindication per the judgment of the site investigator (e.g., Lupus, Type 1 Diabetes, hypertension, or any other known significant disease)

研究者

发起方
Eunice Kennedy Shriver National Institute of Child Health and Human Development

相似试验